Astellas Builds Up Antibodies Pipeline
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)
Published: 1 Jan-2008
DOI: 10.3833/pdr.v2008.i91.233 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
Biologics, in particular antibodies, are playing an increasingly important part in the R&D of big pharma, and it is to be expected that all of the major global players want in...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS